Clinical Trial Update: PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer [NA]

View source ↗

Summary

A Penn Medicine clinical trial evaluating surveillance markers for detecting recurrence after (neo)adjuvant therapy in breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer | NA | Status: RECRUITING